Trial Profile
Exploratory Clinical Study of MT-2301 in Healthy Infants (Phase 2)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2023
Price :
$35
*
At a glance
- Drugs Hib-CRM197 vaccine conjugate (Primary) ; DTP poliovirus vaccine; Hib vaccine conjugate
- Indications Haemophilus infections
- Focus Pharmacodynamics
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 16 Oct 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 08 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Jul 2014 New trial record